Cara Therapeutics Inc. Revenue 2012–2024
Cara Therapeutics Inc. annual/quarterly revenue history and growth rate from 2012 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Cara Therapeutics Inc. revenue for the quarter ending March 31, 2025 was 2.6 M, a 20.33% increase year-over-year.
- Cara Therapeutics Inc. revenue for the twelve months ending March 31, 2025 was 8.3 M, a 71.33% decrease year-over-year.
- Cara Therapeutics Inc. annual revenue for 2024 was 7.1 M, a 65.96% decrease from 2023.
- Cara Therapeutics Inc. annual revenue for 2023 was 21.0 M, a 49.92% decrease from 2022.
- Cara Therapeutics Inc. annual revenue for 2022 was 41.9 M, a 81.81% increase from 2021.
- Cara Therapeutics Inc. annual revenue for 2021 was 23.0 M.
Cara Therapeutics Inc. (TVRD) — Frequently Asked Questions
Cara Therapeutics Inc. (TVRD) is a publicly traded US company. It has a market capitalization of $7M. In fiscal 2024 it reported revenue of $7M and net income of -$29M. Explore TVRD's stock price, financial statements, earnings history, margins and key ratios below.
What is Cara Therapeutics Inc.'s market cap?
Cara Therapeutics Inc. (TVRD) has a market capitalization of $7M.
What is the TVRD stock price?
TVRD trades at $2.70 (-2.88% on the day).
How much revenue does Cara Therapeutics Inc. make?
Cara Therapeutics Inc. reported revenue of $7M in fiscal 2024.
Is TVRD profitable?
In fiscal 2024, Cara Therapeutics Inc. reported net income of -$29M.